Pediatric gliomas compatible with PAAF with a very high mitotic index (in our experience, more than 10 mitoses for 10 HPFs) should benefit from DNA methylation profiling, especially in the context of nonspecific FGFR1 alterations. Here, FGFR1 is linked to central nervous system cancer.